U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[x] Check box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b)
FORM 4
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
Elliott Associates, L.P.
712 Fifth Avenue
New York, New York 10019
2. Issuer Name and Ticker Trading Symbol
Zoll Medical Corporation (ZOLL)
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for (Month/Day/Year)
3/99
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person to Issuer (Check all applicable)
[ ] Director
[ ] Officer (give title below)
[ ] Chairman
[x] 10% Owner
[ ] Other (specify below)
7. Individual or Joint/Group Filing (Check applicable line)
[x] Form filed by one Reporting Person
[ ] Form filed by more than one Reporting Person
(Page 1 of 3)
<PAGE>
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially
Owned
1. Title of Security (Instr. 3)
(a) - (i) Common Stock, par value $.02
2. Transaction Date (Month/Day/Year)
(a) 2/03/99
(b) 2/08/99
(c) 2/10/99
(d) 2/22/99
(e) 3/02/99
(f) 3/08/99
(g) 3/09/99
(h) 3/15/99
(i) 3/16/99
3. Transaction Code (Inst. 8)
Code
(a) - (i) S
V
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
(a) Amount 2,000
(A) or (D) D
Price $11.5000
(b) Amount 1,000
(A) or (D) D
Price $12.0000
(c) Amount 200
(A) or (D) D
Price $11.7500
(d) Amount 1,500
(A) or (D) D
Price $11.4700
(e) Amount 12,500
(A) or (D) D
Price $11.4375
(f) Amount 11,000
(A) or (D) D
Price $12.0497
(g) Amount 10,500
(A) or (D) D
Price $11.9851
(Page 2 of 4)
<PAGE>
(h) Amount 25,000
(A) or (D) D
Price $11.8750
(i) Amount 22,500
(A) or (D) D
Price $12.0625
5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4)
294,500 shares of Common Stock
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
D
7. Nature of Indirect Beneficial Ownership (Instr. 4)
N/A
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Page 3 of 4)
<PAGE>
Table II - Derivative Securities Acquired, Disposed of, or Beneficially
Owned (e.g. puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)
2. Conversion or Exercisable Price of Derivative Security
3. Transaction Date (Month/Day/Year)
4. Transaction Code (Instr. 8)
Code
V
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
(A)
(D)
6. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
Title
Amount or Number of Shares
8. Price of Derivative Security (Inst. 5)
9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership (Instr. 4)
Explanation of Responses:
** Intentional misstatement or omissions of facts constitute Federal Criminal
Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
ELLIOTT ASSOCIATES, L.P.
By: /s/ Paul E. Singer March 18, 1999
Paul E. Singer, General Partner
**Signature of Reporting Person Date
(Page 4 of 4)
